MX2022003770A - Genes relacionados con la resistencia a begomovirus. - Google Patents
Genes relacionados con la resistencia a begomovirus.Info
- Publication number
- MX2022003770A MX2022003770A MX2022003770A MX2022003770A MX2022003770A MX 2022003770 A MX2022003770 A MX 2022003770A MX 2022003770 A MX2022003770 A MX 2022003770A MX 2022003770 A MX2022003770 A MX 2022003770A MX 2022003770 A MX2022003770 A MX 2022003770A
- Authority
- MX
- Mexico
- Prior art keywords
- seq
- substitution
- position corresponding
- modified
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
La presente invención se refiere a un gen de PriL modificado, que codifica una proteína modificada que comprende una o más modificaciones en la secuencia de proteína de tipo salvaje de la SEC ID No. 1 o SEC ID No. 3 o en una secuencia de proteína que tiene al menos un 60 % de identidad de secuencia a la SEC ID No. 1 o SEC ID No. 3. Alternativamente, el tipo salvaje del gen de PriL modificado codifica una proteína de acuerdo con la SEC ID No. 1, SEC ID No. 3, SEC ID No. 7, SEC ID No. 11, SEC ID No. 13, SEC ID No. 15, SEC ID No. 17, SEC ID No. 19, SEC ID No. 21, SEC ID No. 23, SEC ID No. 25, SEC ID No. 27, SEC ID No. 29, o SEC ID No. 31. La modificación en la secuencia de la proteína de tipo salvaje es una sustitución de aminoácidos, en particular una sustitución de fenilalanina (F) por cisteína (C) en una posición correspondiente a la posición 147 de acuerdo con la SEC ID No. 5, y/o sustitución de glicina (G) por ácido aspártico (D) en una posición correspondiente a la posición 162 de acuerdo con la SEC ID No. 5, y/o sustitución de glutamina (Q) por histidina (H) en una posición correspondencia de posición correspondiente a la posición 163 de acuerdo con la SEC ID No. 5, y/o en donde el gen modificado codifica una proteína modificada que comprende una sustitución de tirosina (Y) por histidina (H) en una posición correspondiente a la posición 4 de acuerdo con la SEC ID No. 9, y/o una sustitución de prolina (P) por glutamina (Q) en una posición correspondiente a la posición 166 de acuerdo con la SEC ID No. 9, y/o una sustitución de isoleucina (I) por treonina (T) en una posición correspondiente a la posición 200 de acuerdo con la SEC ID No. 9.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP2019/076611 | 2019-10-01 | ||
| PCT/EP2020/077558 WO2021064118A1 (en) | 2019-10-01 | 2020-10-01 | Begomovirus resistance related genes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022003770A true MX2022003770A (es) | 2022-04-20 |
Family
ID=68136409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022003770A MX2022003770A (es) | 2019-10-01 | 2020-10-01 | Genes relacionados con la resistencia a begomovirus. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220267791A1 (es) |
| EP (1) | EP4038193A1 (es) |
| AU (1) | AU2020360701A1 (es) |
| CR (1) | CR20220137A (es) |
| IL (1) | IL291792A (es) |
| MX (1) | MX2022003770A (es) |
| WO (1) | WO2021064118A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022189674A1 (en) * | 2021-03-12 | 2022-09-15 | Rijk Zwaan Zaadteelt En Zaadhandel B.V. | QTLs FOR MCLCV RESISTANCE IN C. MELO |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017115353A1 (en) * | 2015-12-28 | 2017-07-06 | Evogene Ltd. | Plant traits conferred by isolated polynucleotides and polypeptides |
-
2020
- 2020-10-01 MX MX2022003770A patent/MX2022003770A/es unknown
- 2020-10-01 AU AU2020360701A patent/AU2020360701A1/en active Pending
- 2020-10-01 CR CR20220137A patent/CR20220137A/es unknown
- 2020-10-01 WO PCT/EP2020/077558 patent/WO2021064118A1/en unknown
- 2020-10-01 IL IL291792A patent/IL291792A/en unknown
- 2020-10-01 EP EP20780237.2A patent/EP4038193A1/en active Pending
-
2022
- 2022-03-21 US US17/699,346 patent/US20220267791A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4038193A1 (en) | 2022-08-10 |
| IL291792A (en) | 2022-06-01 |
| AU2020360701A1 (en) | 2022-09-01 |
| CR20220137A (es) | 2022-08-04 |
| WO2021064118A1 (en) | 2021-04-08 |
| US20220267791A1 (en) | 2022-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4272765A3 (en) | Adeno-associated virus (aav) clade f vector and uses therefor | |
| DE602005020165D1 (de) | Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin | |
| UA124343C2 (uk) | Капсиди аденоасоційованого вірусу і спосіб його використання | |
| JP2017121261A5 (es) | ||
| NZ602351A (en) | Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184 : vip3a insecticidal proteins from bacillus thuringiensis and methods for their use | |
| NZ603348A (en) | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | |
| MX2019015502A (es) | L-asparaginasa modificada. | |
| BR112021021912A2 (pt) | Nova nuclease omni-50 crispr | |
| MX2021004714A (es) | Proteina cas9 modificada, y uso de la misma. | |
| CR20220137A (es) | Genes relacionados con la resistencia a begomovirus | |
| JP2019500414A5 (es) | ||
| NZ781143A (en) | Anti-vegf protein compositions and methods for producing the same | |
| MX2021013743A (es) | Subunidad s1 modificada de la proteina de espicula de coronavirus. | |
| MX2021014856A (es) | Vacuna de tgf-beta. | |
| JP2019509717A5 (es) | ||
| WO2008113536A8 (en) | Neurotrophic peptides | |
| PH12017550134A1 (en) | Il-37 variants | |
| MX2018003162A (es) | Variante en el numero de copias que genera resistencia a virus. | |
| PH12018500468A1 (en) | Fusion protein | |
| MX2022006616A (es) | Gen cca para la resistencia a los virus. | |
| EP4282960A3 (en) | Modified lipase and use thereof | |
| ATE551353T1 (de) | Protein mit fusogener wirkung, nukleinsäuresequenzen, die für dieses protein codieren und pharmazeutische zusammensetzungen, die dieses enthalten | |
| MX2021001671A (es) | Barrita proteica. | |
| EA201992349A1 (ru) | Fgfr3-связывающие молекулы | |
| MX2022007237A (es) | Variante del virus de la vacuna oncolitica y metodos de uso del mismo. |